Data_Sheet_1_High APRIL Levels Are Associated With Slow Disease Progression and Low Immune Activation in Chronic HIV-1-Infected Patients.pdf
Objective: B-cell-activating factor (BAFF) has been determined to be involved in HIV-1 infection and is correlated with disease progression, while its homologous molecule, a proliferation-inducing ligand (APRIL), is less frequently reported, and its role remains unclear. We aimed to characterize the APRIL levels in subjects with different HIV-1 infection statuses and determine the relationships with disease progression and immune activation.
Methods: The plasma levels of APRIL were compared among 17 long-term non-progressors (LTNPs), 17 typical progressors (TPs), 10 ART-treated patients, and 10 healthy donors (HDs). Seventeen LTNPs and a subset of TPs (n = 6) who initiated ART were assessed longitudinally. The correlations between the APRIL levels and markers of disease progression, B-cell count and specific antibody response, and markers of immune activation and functional cells were analyzed.
Results: The circulating APRIL levels were significantly elevated in the LTNPs relative to the TPs, ART-treated patients, and HDs. The longitudinal investigation revealed that the APRIL levels were decreased during follow-up in the LTNPs. ART did not significantly influence the APRIL levels. The levels of plasma APRIL were negatively correlated with the plasma HIV-1 viral load and cellular HIV-1 DNA levels and positively correlated with the CD4+ T-cell count and CD4/CD8 ratio. An inverse correlation was observed between the APRIL and BAFF levels. Furthermore, the APRIL levels were negatively correlated with the frequency of activated CD8+ T cells and levels of interferon gamma-induced protein 10 (IP-10) and monocyte chemoattractant protein-1 (MCP-1). Finally, positive correlations were observed among the APRIL levels, the frequency of CD8+CD28+ T cells, and natural killer (NK) cell count.
Conclusion: The APRIL levels were elevated in the LTNPs and negatively correlated with disease progression and immune activation, suggesting likely protective activity in HIV-1 infection.
History
References
- https://doi.org//10.1371/journal.ppat.1006285
- https://doi.org//10.1097/QAD.0000000000002173
- https://doi.org//10.3389/fimmu.2018.01469
- https://doi.org//10.1038/s41598-019-44198-z
- https://doi.org//10.1097/QAD.0000000000000174
- https://doi.org//10.1093/infdis/jiz252
- https://doi.org//10.1111/imr.12502
- https://doi.org//10.3389/fimmu.2017.01338
- https://doi.org//10.1182/blood-2010-08-301887
- https://doi.org//10.1097/00002030-200309050-00018
- https://doi.org//10.1128/CMR.00046-17
- https://doi.org//10.1080/08830185.2016.1276903
- https://doi.org//10.7150/jca.15966
- https://doi.org//10.1681/ASN.2016050496
- https://doi.org//10.1097/QAD.0000000000000965
- https://doi.org//10.1128/JVI.02622-09
- https://doi.org//10.1086/528695
- https://doi.org//10.1097/QAD.0b013e32833243e7
- https://doi.org//10.1186/s12879-017-2866-y
- https://doi.org//10.18632/aging.100894
- https://doi.org//10.1128/JVI.02108-09
- https://doi.org//10.1002/art.21650
- https://doi.org//10.1136/ard.2006.060772
- https://doi.org//10.1182/blood-2011-01-332940
- https://doi.org//10.1158/0008-5472.CAN-16-0786
- https://doi.org//10.1002/eji.200737210
- https://doi.org//10.1038/mi.2016.57
- https://doi.org//10.1172/JCI15034
- https://doi.org//10.1128/mcb.24.3.997-1006.2004
- https://doi.org//10.1073/pnas.0307348101
- https://doi.org//10.1016/j.cellimm.2019.103925
- https://doi.org//10.1038/mi.2014.134
- https://doi.org//10.4049/jimmunol.1601882
- https://doi.org//10.1084/jem.20032000
- https://doi.org//10.4049/jimmunol.176.7.3931
- https://doi.org//10.1038/nm.4187
- https://doi.org//10.1136/ard.2008.090928
- https://doi.org//10.1016/j.jaut.2016.06.002
- https://doi.org//10.3389/fimmu.2019.01368
- https://doi.org//10.1002/ana.25415
- https://doi.org//10.1016/s1074-7613(03)00025-6
- https://doi.org//10.1038/nrd1982
- https://doi.org//10.4049/jimmunol.169.8.4314
- https://doi.org//10.1186/ar2959
- https://doi.org//10.1172/JCI195
- https://doi.org//10.1046/j.1365-2249.2000.01153.x
- https://doi.org//10.1007/s11904-016-0310-3
- https://doi.org//10.1084/jem.20060894
- https://doi.org//10.1097/QAD.0000000000001645
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Medical Genetics (excl. Cancer Genetics)
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Primary Health Care
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care
